(Q37162812)

18 August 2017

1 reference

title

Clinical questions and uncertainty--prolactin measurement in patients with schizophrenia and bipolar disorder (English)

1 reference

18 August 2017

0 references

1 reference

James Walters

1

1 reference

18 August 2017

Ian Jones

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

Journal of Psychopharmacology

18 August 2017

published in

1 reference

18 August 2017

volume

22

1 reference

18 August 2017

issue

2 Suppl

1 reference

18 August 2017

page(s)

82-89

1 reference

Effects of short and long-term lithium treatment on serum prolactin levels in patients with bipolar affective disorder

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Review of Antipsychotic Medication Administration: A Proposal of Intermittent Dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Annual cost of bipolar disorder to UK society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Prolactin and dopamine: what is the connection? A review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Adverse effects of prolactin in rodents and humans: breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Abnormal prolactin response to haloperidol challenge in men with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Prolactin levels and adverse events in patients treated with risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

21 January 2018

Costs of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Physical health monitoring of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Lifetime prevalence of psychotic and bipolar I disorders in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

The impact of hyperprolactinaemia on sexual function in patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Effectiveness of switching to quetiapine for neuroleptic-induced amenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

Elevated prolactin in pediatric patients on typical and atypical antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107086516

21 January 2018

Identifiers

DOI

10.1177/0269881107086516

1 reference

18 August 2017

1 reference